GlaxoSmithKline Price on June 3, 2020 Breakdown

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Report: 22nd of July 2020  

GlaxoSmithKline PLC stock price history is provided at the adjusted bases, taking into account all of the recent filings. As of today the current price of GlaxoSmithKline PLC is  40.37 , as last reported on the 10th of July, with the highest price reaching  41.00  and the lowest price hitting  40.12  during the day. We consider GlaxoSmithKline PLC very steady. GlaxoSmithKline PLC holds Efficiency (Sharpe) Ratio of 0.0448, which attests that the entity had 0.0448% of return per unit of standard deviation over the last 3 months. Our philosophy in determining the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for GlaxoSmithKline PLC, which you can use to evaluate future volatility of the firm. Please check out GlaxoSmithKline PLC risk adjusted performance of 0.1775, and market risk adjusted performance of 0.3764 to validate if the risk estimate we provide is consistent with the expected return of 0.069%.

Search Stock Price History

 
Refresh
The current Net Income Common Stock is estimated to decrease to about 4.1 B. The current Price to Book Value is estimated to increase to 9.09. The current Price to Earnings Ratio is estimated to increase to 25.29.

Related Headline

Gilead Sciences Headline on 3rd of June 2020

Gilead Upgraded With Covid Sales Seen Reaching 7.7 Billion Yahoo FinanceBetter Buy Bristol Myers Squibb vs. Gilead Sciences Motley FoolGileads stock upgraded on high hopes for remdesivir revenue MarketWatchGilead Falls as Drug Has Only Small Benefit in Large Trial BloombergGilead Sciences Stock Rose 1.5 percent Yesterday on Remdesivir 7 Billion Sales... CoinspeakerView Full Coverage on Google News

GlaxoSmithKline PLC Valuation Near June 3, 2020

 Open High Low Close Volume
  41.69    42.06    41.55    42.03    1,990,933  
 06/03/2020 
  42.19    42.32    42.07    42.12    2,637,416  
  41.74    42.13    41.60    41.65    2,800,098  
Backtest GlaxoSmithKline PLC  |  GlaxoSmithKline PLC History  |  GlaxoSmithKline PLC Valuation   PreviousNext  
Open Value
42.19
3rd of June 2020
 
42.12
Closing Value
46.81
Upside
 

GlaxoSmithKline PLC Trading Date Momentum on June 3, 2020

On June 04 2020 GlaxoSmithKline PLC was traded for  41.65  at the closing time. Highest GlaxoSmithKline PLC's price during the trading hours was 42.13  and the lowest price during the day was  41.60 . The net volume was 2.8 M. The overall trading history on the 4th of June contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 1.12% . The overall trading delta to current price is 4.49% .

GlaxoSmithKline PLC Fundamentals Correlations and Trends

About GlaxoSmithKline PLC Stock history

GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC historical stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
Last ReportedProjected for 2020
Weighted Average Shares5.4 B5.9 B
Weighted Average Shares DilutedB5.5 B
Issuance Purchase of Equity Shares51 M55 M
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments Pharmaceuticals, Pharmaceuticals RD, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe Merck KGaA Lyell Immunopharma CEPI Innovax and Xiamen University VBI Viome Sanofi SA and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GlaxoSmithKline PLC Stock Technical Analysis

GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

GlaxoSmithKline PLC Period Price Range

Low
June 3, 2020
High
 42.19 
  
 42.12 
-0.07-0.17%

GlaxoSmithKline PLC July 10, 2020 Market Strength

GlaxoSmithKline PLC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GlaxoSmithKline stock's direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline PLC historical stock price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance0.1775
Jensen Alpha0.0803
Total Risk Alpha0.0071
Sortino Ratio(0.009143)
Treynor Ratio0.3664
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Please check Risk vs Return Analysis. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page